Home

HOPA Conference 2018 promo
  • HOPA 2018 conference promo
  • Time to Talk CINV

Upcoming Events


HOPA News

Check out the latest edition of HOPA News!

HOPA News Volume 14 issue 4

Latest Discussions

HOPA Bulletin

  • Follicular lymphoma (FL) is an indolent malignancy of germinal center B cells. Although the overall survival of FL patients has recently improved with the introduction of novel therapies, there is significant heterogeneity in patient outcome and a need for rationally designed therapeutic strategies that target disease biology. Next-generation sequencing studies have identified chromatin modifying gene (CMG) mutations as a hallmark of FL, highlighting epigenetic modifiers as an attractive therapeutic target in this disease.

Getting Started

Check out our user guide for further information.

Recent Shared Files

Connect With Us